272 related articles for article (PubMed ID: 15936582)
21. A new method for synthesizing radiation dose-response data from multiple trials applied to prostate cancer: in regard to Diez P, et al. (Int J Radiat Oncol Biol Phys 2010;77:1066-1071).
Williams SG
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):639; author reply 639-40. PubMed ID: 21549251
[No Abstract] [Full Text] [Related]
22. In regards to Thames et al.: increasing external beam dose for T1-T2 prostate cancer: effect on risk groups. (Int J Radiat Oncol Biol Phys 2006;65:975-981).
Pickles T; Williams SG
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):318-9; author reply 319. PubMed ID: 17189080
[No Abstract] [Full Text] [Related]
23. Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy: in regard to Georg et al. (Int J Radiat Oncol Biol Phys 2011;79:356-362).
Shi M; Wei L
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):315; author reply 315-6. PubMed ID: 21816293
[No Abstract] [Full Text] [Related]
24. In regard to Pisch et al: placement of 125I implants with the da Vinci robotic system after video-assisted thoracoscopic wedge resection: a feasibility study (INT J RADIAT ONCOL BIOL PHYS 2004;60:928-932).
Colonias A; Parda DS
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1277-8; author reply 1278. PubMed ID: 15752912
[No Abstract] [Full Text] [Related]
25. What can we conclude from the results of an out-of-date breast brachytherapy study? In regard to Póti Z, Nemeskéri C, Fekeshazy A, et al. (Int J Radiat Oncol Biol Phys 2004;58:1022-1033).
Polgár C; Major T; Strnad V; Inoue T; Guedea F
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):342-3; author reply 343-5. PubMed ID: 15337574
[No Abstract] [Full Text] [Related]
26. Prostate postbrachytherapy seed distribution: comparison of high-resolution, contrast-enhanced, T1- and T2-weighted endorectal magnetic resonance imaging versus computed tomography: initial experience: in regard to BLOCH et al. (Int J Radiat Oncol Biol Phys 2007;69:70-78).
Beaulieu L; Verhaegen F
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1289; author reply 1289-90. PubMed ID: 18572093
[No Abstract] [Full Text] [Related]
27. In regard to Dr. Vasanthan et al. (Int J Radiat Oncol Biol Phys 2005;61:145-153).
van der Zee J; van Rhoon GC; Wust P
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):940-1. PubMed ID: 15936581
[No Abstract] [Full Text] [Related]
28. Lung V20 measurements: In regard to Seppenwoolde et al. (Int J Radiat Oncol Biol Phys 2003;55:724-735), and Tsujino et al. (Int J Radiat Oncol Biol Phys 2003;56:1208-1209).
Garces YI; Miller RC
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1636; author reply 1636-7. PubMed ID: 15050346
[No Abstract] [Full Text] [Related]
29. Comment on dose escalation and biochemical failure in prostate cancer: in regard to Kuban et al. (Int J Radiat Oncol Biol Phys 2008;70:67-74).
Schulz RJ; Kagan AR
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1288; author reply 1288-9. PubMed ID: 18572089
[No Abstract] [Full Text] [Related]
30. Commentary on dose escalation and biochemical failure in prostate cancer: in regard to Eade et al. (Int. J. Radiat. Oncol. Biol. Phys. 2007;68:682-689).
Schulz RJ; Kagan AR
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):645; author reply 645-6. PubMed ID: 18207038
[No Abstract] [Full Text] [Related]
31. PSA failure and the risk of death in prostate cancer patients treated with radiotherapy: in regard to Kwan et al. (Int J Radiat Oncol Biol Phys 2004;60:1040-1046).
Williams S
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1253-4; author reply 1254. PubMed ID: 15990030
[No Abstract] [Full Text] [Related]
32. The need and prospect of individualized external beam radiotherapy dose escalation beyond 80 gy to treat prostate cancer: in regard to Eade et al. (Int J. Radiat. Oncol. Biol. Phys. 2007;68:682-689).
Cheung MR
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):645; author reply 645-6. PubMed ID: 18207039
[No Abstract] [Full Text] [Related]
33. CTV margins in prostate cancer irradiation. In regard to Teh et al.: IMRT for prostate cancer: defining target volume based on correlated pathologic volume of disease (Int J Radiat Oncol Biol Phys 2003;56:184-191).
Macias V
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):320-1; author reply 321-2. PubMed ID: 15093933
[No Abstract] [Full Text] [Related]
34. Time course of prostatic edema post permanent seed implant determined by magnetic resonance imaging.
Sloboda RS; Usmani N; Pedersen J; Murtha A; Pervez N; Yee D
Brachytherapy; 2010; 9(4):354-61. PubMed ID: 20116344
[TBL] [Abstract][Full Text] [Related]
35. Radiobiological parameters suitable for modeling individual outcomes cannot be obtained by analyzing heterogeneous population data with homogeneous tumor control model: in regard to D'Souza et al. (Int J Radiat Oncol Biol Phys 2004;58:1540-1548).
Carlone M; Wilkins D; Raaphorst GP
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):298-9. PubMed ID: 15850946
[No Abstract] [Full Text] [Related]
36. Biologic comparisons of partial breast irradiation schedules: In regard to Rosenstein et al. (Int J Radiat Oncol Biol Phys 2004;60:1391-1404).
Morgan DA
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):943; author reply 943-4. PubMed ID: 15936586
[No Abstract] [Full Text] [Related]
37. Radiation dose is predictive of biochemical failure, local failure, and distant metastases. In regard to Kupelian et Al. (Int J Radiat Oncol Biol Phys 2008;71:16-22).
Kelly P
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1621-2; author reply 1622. PubMed ID: 19028291
[No Abstract] [Full Text] [Related]
38. Brachytherapy vs. IMRT for irradiation of the vaginal vault: in regard to Aydogan et al. (Int J Radiat Oncol Biol Phys 2006;65:266-273).
Cameron A; Cornes P
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):956; author reply 956-7. PubMed ID: 17011468
[No Abstract] [Full Text] [Related]
39. Cyberknife and prostate cancer. In regard to King et al. (Int J Radiat Oncol Biol Phys 2009;73:1043-1048).
Vikram B
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):632. PubMed ID: 19735890
[No Abstract] [Full Text] [Related]
40. Randomized comparison of whole brain radiotherapy, 20 Gy in four daily fractions versus 40 Gy in 20 twice-daily fractions, for brain metastases. In regard to Graham et al. (Int J Radiat Oncol Biol Phys 2010;77(3):648-54.).
Davey P; Smith J; Ennis M
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1605-6; author reply 1606. PubMed ID: 21092835
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
